These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3629586)

  • 21. [Cefonicid toxicity. I. Effects on the reactivity of the specific immune system].
    Gariglio M; Franco A; Gribaudo G; Martinotti MG; Landolfo S; Cavallo G
    G Batteriol Virol Immunol; 1987; 80(1-12):225-30. PubMed ID: 3509030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of the toxic functional group of cephalosporins by zebrafish embryo toxicity test.
    Zhang J; Meng J; Li Y; Hu C
    Arch Pharm (Weinheim); 2010 Oct; 343(10):553-60. PubMed ID: 20938949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefonicid concentration in lung tissue after intramuscular administration.
    Cruciani M; Savio S; Concia E
    Int J Clin Pharmacol Res; 1987; 7(6):481-4. PubMed ID: 3440639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic analysis of a new drug: potential savings in hospital operating costs from the use of a once-daily regimen of a parenteral cephalosporin.
    Eisenberg JM; Koffer H; Finkler SA
    Rev Infect Dis; 1984; 6 Suppl 4():S909-23. PubMed ID: 6441226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma and myocardial levels of cefonicid during open-heart surgery.
    Sterling RP; Connor DJ; Norman JC
    J Natl Med Assoc; 1983 Nov; 75(11):1075-80. PubMed ID: 6655710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compatibility of clindamycin phosphate with aztreonam in polypropylene syringes and with cefoperazone sodium, cefonicid sodium, and cefuroxime sodium in partial-fill glass bottles.
    Marble DA; Bosso JA; Townsend RJ
    Drug Intell Clin Pharm; 1988 Jan; 22(1):54-7. PubMed ID: 3349921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. II. Pharmacokinetics in comparison with cefazolin.
    Pabst J; Leopold G; Ungethüm W; Dingeldein E
    Arzneimittelforschung; 1979; 29(2a):437-43. PubMed ID: 582722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-over study of the pharmacokinetics of cefonicid administered intravenously or intramuscularly to healthy adult humans.
    Fourtillan JB; Leroy A; Lefebvre MA; Humbert G; Fillastre JP; Reumont G; Ramis N
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):225-30. PubMed ID: 3936717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin.
    Mini E; Mazzei T; Periti P; Reali EF; Bordonaro P; Balocchini E; Ninu B
    Chemioterapia; 1987 Apr; 6(2):95-8. PubMed ID: 3594635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue penetration and half-life of cefonicid.
    Nightingale CH; Quintiliani R; Dudley MN; Gough P; Hickingbotham M; Jordan NS; Rose D; Toscani M
    Rev Infect Dis; 1984; 6 Suppl 4():S821-8. PubMed ID: 6522924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioavailability in human volunteers of three intramuscular formulations of cefonicid: a long-acting cephalosporin.
    Brumfitt W; James I; Hamilton-Miller JM; Grady D; Price C
    Biopharm Drug Dispos; 1988; 9(3):251-7. PubMed ID: 3395666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penetration of cefonicid in skin suction blister fluid in healthy volunteers.
    Cruciani M; Concia E; Passarella E; Soncini R
    Int J Clin Pharmacol Res; 1987; 7(3):225-7. PubMed ID: 3596863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of cefonicid and cefoxitin for preventing infections after vaginal hysterectomy.
    Mercer LJ; Murphy HJ; Ismail MA; Hajj SN
    J Reprod Med; 1988 Feb; 33(2):223-6. PubMed ID: 3351823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenteral antibiotic therapy at home: experience with intramuscular cefonicid.
    Nadworny HA; Markowitz A
    Clin Ther; 1987; 10(1):82-91. PubMed ID: 3450394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease.
    McCabe RE; Schlossberg D; Donowitz GR; Scheld WM; Zellner SR; Lindenberg LB; Armstrong JH; Ein ME
    Clin Ther; 1989; 11(3):304-14. PubMed ID: 2663160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-dose antibiotic prophylaxis in women undergoing vaginal hysterectomy.
    Soper DE; Yarwood RL
    Obstet Gynecol; 1987 Jun; 69(6):879-82. PubMed ID: 3574819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Affinity of cefonicid, a long-acting cephalosporin, for the penicillin-binding proteins of Escherichia coli K-12.
    Rake JB; Newman DJ; Actor P
    J Antibiot (Tokyo); 1984 May; 37(5):572-6. PubMed ID: 6376452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics and renal handling of cefonicid.
    Pitkin D; Dubb J; Actor P; Alexander F; Ehrlich S; Familiar R; Stote R
    Clin Pharmacol Ther; 1981 Nov; 30(5):587-93. PubMed ID: 7297018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-performance liquid chromatographic determination of cefonicid in human plasma and urine.
    Brendel E; Zschunke M; Meineke I
    J Chromatogr; 1985 May; 339(2):359-65. PubMed ID: 4008574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin.
    Mini E; Mazzei T; Periti P; Reali EF; Bordonaro P; Balocchini E; Ninu B
    Chemioterapia; 1987 Jun; 6(2 Suppl):243-6. PubMed ID: 3509398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.